MARKHAM, ON, Aug. 10
/PRNewswire-FirstCall/ - AlphaRx Inc. (OTC BB:ALRX.OB - News), an
emerging biopharmaceutical company utilizing proprietary drug delivery
technology to develop novel...
AlphaRx's specially-formulated Tobramycin nanoparticles increase
survival rate in mice infected with Gram negative Pseudomonas
Aeruginosa, suggesting Zysolin has potential in the treatment of...
AlphaRx CEO Buys More Company Shares
MARKHAM, ON, Dec. 13 /PRNewswire-FirstCall/ - AlphaRx (OTC BB:ALRX - News)
stated on Thursday that CEO Michael Lee purchased...
MARKHAM, ON, Dec. 11 /PRNewswire-FirstCall/ - AlphaRx (OTC BB:ALRX - News) AlphaRx, a leader in the development of Nanotechnology for Drug Delivery Platforms, is pleased to announce that it has...
MARKHAM, ON, Dec. 6 /PRNewswire-FirstCall/ - AlphaRx (OTC BB:ALRX - News) AlphaRx, a leader in the development of Nanotechnology for Drug Delivery Platforms, announced a major product...
MARKHAM, ON, Nov. 29 /PRNewswire-FirstCall/ - AlphaRx (OTC BB:ALRX - News) The chief executive of AlphaRx (OTCBB:ALRX), Michael Lee, announced In a U.S. Securities and Exchange Commission...
StockProfit.com Small-Cap Highlight: AlphaRX Inc. (OTCBB: ALRX)
StockProfit.com features AlphaRx Inc. (OTCBB: ALRX) as its Small-Cap Highlight for the week of December 3rd, 2007
Los...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dutton Associates updates its coverage of AlphaRX (OTCBB:ALRX)
maintaining a Speculative Buy rating. The 10-page report by Dutton
senior...
AlphaRx Receives Notice of Allowance for U.S. Patent on Its Drug Delivery Platform
MARKHAM, Ontario, Jan. 25, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX message board, news, dd, quote), an...